micro-community-banner
  • Saved

Did you know? Stanford University made a groundbreaking advance with COSMOS, a bifocal microscopy technique that captures real-time movies of neural activity across the entire cerebral cortex of a mouse brain. By filming from three angles and computationally extracting the signals, they created a live video showing the brain's macroscopic activity, revealing the dynamic "electrical storm" of brain function in action.

How could this new method of visualizing brain activity transform our understanding of neural processes and neurological disorders?

background

How could this new method of visualizing brain activity transform our understanding of neural processes and neurological disorders?

  • Saved

Did you know? Originally developed in Switzerland, the HypoCat™ vaccine helps to reduce cat allergies by neutralizing Fel D 1, the protein most responsible for causing allergic reactions to cat dander in humans. When given to cats, the vaccine triggers their immune system to create antibodies against Fel D 1. Results from four separate studies have reported that the HypoCat™ vaccine caused no negative side effects for cats. The vaccine is projected to be available in the U.S. by the end of 2024. A similar vaccine for dogs is currently in the early stages of development.

How could vaccines like HypoCat™ revolutionize allergy treatments and improve the lives of pet owners with allergies?

background

How could vaccines like HypoCat™ revolutionize allergy treatments and improve the lives of pet owners with allergies?

  • Saved
Background Image DesktopBackground Image Mobile

Self-control isn't always effortful. Research shows successful self-control links to quick conflict resolution, automated habits, and strategic anticipation. By building better habits and planning for challenges, self-control becomes less about resisting impulses and more about effortless, effective strategies.

Read More

  • Saved
Thrombotic Microangiopathy as a Life-Threatening Complication of Long-Term Interferon Beta Therapy for Multiple Sclerosis: Clinical Phenotype and Response to Treatment-A Literature Review - PubMed

Thrombotic Microangiopathy as a Life-Threatening Complication of Long-Term Interferon Beta Therapy for Multiple Sclerosis: Clinical Phenotype and Response to Treatment-A Literature Review - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38541824/

Thrombotic microangiopathy (TMA) has been observed in some patients receiving interferon beta (IFNβ) therapy for relapsing-remitting multiple sclerosis, but little is known about its clinical features and outcomes. We searched...

Thrombotic microangiopathy (TMA) in IFNβ-treated multiple sclerosis patients often presents with acute kidney injury, prodromal symptoms, and is treated with plasma exchange or eculizumab, improving renal outcomes in severe cases.

  • Saved
Comments on energy conservation treatments for MS-related fatigue and a new proposal - PubMed

Comments on energy conservation treatments for MS-related fatigue and a new proposal - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38735103/

Psychological treatments of MS-related fatigue mostly depend on energy conservation programs. We argue that the evidence for energy conservation training is weak - in contrast to some reviews on this...

The authors critique energy conservation programs for MS-related fatigue and propose a three-step treatment approach, focusing on fatigue as a subjective feeling, using Progressive Muscle Relaxation to interrupt fatigue and improve treatment outcomes.